\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ fully\\ alert\\ and\\ oriented\\.\\ his\\ neurological\\ exam\\ revealed\\ a\\ right\\ sided\\ hemiparesis\\ with\\ strengths\\ of\\ 2\\/5\\ in\\ his\\ right\\ lower\\ extremity\\ and\\ 3\\/5\\ in\\ the\\ right\\ upper\\ extremity\\.\\ he\\ was\\ hyperreflexic\\ right\\ greater\\ than\\ left\\,\\ had\\ right\\ sided\\ spasticity\\,\\ and\\ a\\ right\\ babinski\\ present\\ with\\ clonus\\ in\\ the\\ ankle\\.\\ he\\ also\\ had\\ decreased\\ sensation\\ to\\ light\\ touch\\ throughout\\ his\\ right\\ side\\ including\\ his\\ face\\.\ \(0\)\
\-\ this\\ patient\\ received\\ a\\ six\\ week\\ course\\ or\\ radiation\\ and\\ will\\ start\\ a\\ phase\\ 2\\ clinical\\ chemotherapy\\ trial\\ at\\ the\\ nih\\.\\ he\\ was\\ also\\ started\\ on\\ seizure\\ prophylaxis\\ and\\ pain\\ medication\\.\ \(0\)\
\-\ solitary\\ deep\\ lesion\\ with\\ mild\\ midline\\ shift\\ and\\ patchy\\ enhancement\\.\\ \\ abnormal\\ white\\ matter\\ signal\\ in\\ the\\ right\\ hemisphere\\ suggesting\\ tumor\\ extension\\ across\\ the\\ corpus\\ callosum\\.\ \(0\)\
\-\ brain\\ biopsy\\ confirmed\\ glioblastoma\\ multiforme\\.\ \(0\)\
\-\ \\<li\\>astrocytoma\\ \\-\\ anaplastic\\ \\(usually\\ does\\ not\\ show\\ \\'cystic\\'\\ or\\ necrotic\\ area\\)\ \(0\)\
\-\ \\<li\\>glioblastoma\\ multiforme\\ \\(usually\\ brighter\\ enhancement\\)\ \(0\)\
\-\ \\<li\\>primary\\ cns\\ lymphoma\\ \\(usually\\ lower\\ signal\\ on\\ t2w\\)\ \(0\)\
\-\ \\<li\\>tumefactive\\ demyelination\\ \\(usually\\ does\\ not\\ show\\ edema\\ like\\ this\\)\ \(0\)\
\-\ this\\ patient\\ presented\\ with\\ 3\\ weeks\\ of\\ progressive\\ weakness\\ in\\ right\\ upper\\ and\\ lower\\ extremities\\.\ \(0\)\
\-\ gliomas\\ are\\ graded\\ on\\ the\\ most\\ aggressive\\ histology\\.\\ \\ a\\ small\\ region\\ of\\ gbm\\ may\\ arise\\ or\\ coexist\\ within\\ larger\\ areas\\ of\\ anaplastic\\ astrocytoma\\.\\ \\ gbm\\ usually\\ presents\\ in\\ older\\ patients\\ \\(typically\\ \\>40\\ yrs\\.\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.29833083506457214\ \(0\)\
\-\ usually\\:\\ 0\\.24758475449742923\ \(0\)\
\-\ right\\:\\ 0\\.23469986731997688\ \(0\)\
\-\ his\\:\\ 0\\.1908121976786476\ \(0\)\
\-\ anaplastic\\:\\ 0\\.17264413249063773\ \(0\)\
\-\ gbm\\:\\ 0\\.16633324701618046\ \(0\)\
\-\ multiforme\\:\\ 0\\.16393368810156447\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.15687567763550944\ \(0\)\
\-\ he\\:\\ 0\\.1397318388454653\ \(0\)\
\-\ lower\\:\\ 0\\.12058011191904619\ \(0\)\
\-\ coexist\\:\\ 0\\.12019741926514253\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.11875652693893807\ \(0\)\
\-\ in\\:\\ 0\\.11740256122472933\ \(0\)\
\-\ and\\:\\ 0\\.1137732904126806\ \(0\)\
\-\ extremity\\:\\ 0\\.11330384440876608\ \(0\)\
\-\ hyperreflexic\\:\\ 0\\.11315376462060081\ \(0\)\
\-\ brighter\\:\\ 0\\.11315376462060081\ \(0\)\
\-\ does\\:\\ 0\\.10875334434044197\ \(0\)\
\-\ spasticity\\:\\ 0\\.10504891224120234\ \(0\)\
\-\ sided\\:\\ 0\\.10119126917558134\ \(0\)\
\-\ show\\:\\ 0\\.09986544813289365\ \(0\)\
\-\ strengths\\:\\ 0\\.09800525759666062\ \(0\)\
\-\ babinski\\:\\ 0\\.09711535107472243\ \(0\)\
\-\ clonus\\:\\ 0\\.09627941239200173\ \(0\)\
\-\ start\\:\\ 0\\.09474574821211884\ \(0\)\
\-\ the\\:\\ 0\\.09416849341796762\ \(0\)\
\-\ demyelination\\:\\ 0\\.09152448785437231\ \(0\)\
\-\ gliomas\\:\\ 0\\.09096160295211891\ \(0\)\
\-\ enhancement\\:\\ 0\\.09054620350951588\ \(0\)\
\-\ tumefactive\\:\\ 0\\.08939894030662061\ \(0\)\
\-\ signal\\:\\ 0\\.08917585266312979\ \(0\)\
\-\ graded\\:\\ 0\\.08891507433304334\ \(0\)\
\-\ trial\\:\\ 0\\.08755770727113235\ \(0\)\
\-\ yrs\\:\\ 0\\.08755770727113235\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.08672176858841166\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.08672176858841166\ \(0\)\
\-\ fully\\:\\ 0\\.08482993452249271\ \(0\)\
\-\ upper\\:\\ 0\\.08406524021653017\ \(0\)\
\-\ histology\\:\\ 0\\.08348362057966499\ \(0\)\
\-\ or\\:\\ 0\\.08208920578845029\ \(0\)\
\-\ this\\:\\ 0\\.08108299284018827\ \(0\)\
\-\ t2w\\:\\ 0\\.07935743052945325\ \(0\)\
\-\ nih\\:\\ 0\\.07843783881775472\ \(0\)\
\-\ had\\:\\ 0\\.0783787563155706\ \(0\)\
\-\ touch\\:\\ 0\\.07716412478482158\ \(0\)\
\-\ patient\\:\\ 0\\.07674867573371986\ \(0\)\
\-\ patchy\\:\\ 0\\.07656883383870289\ \(0\)\
\-\ across\\:\\ 0\\.07656883383870289\ \(0\)\
\-\ necrotic\\:\\ 0\\.07656883383870289\ \(0\)\
\-\ callosum\\:\\ 0\\.07408725072351983\ \(0\)\
\-\ also\\:\\ 0\\.0739951828357442\ \(0\)\
\-\ hemisphere\\:\\ 0\\.07360897970450014\ \(0\)\
\-\ cns\\:\\ 0\\.07345317278890563\ \(0\)\
\-\ older\\:\\ 0\\.07299604478243847\ \(0\)\
\-\ medication\\:\\ 0\\.07269950076576535\ \(0\)\
\-\ alert\\:\\ 0\\.07240920024719216\ \(0\)\
\-\ solitary\\:\\ 0\\.07198489706738999\ \(0\)\
\-\ arise\\:\\ 0\\.07198489706738999\ \(0\)\
\-\ corpus\\:\\ 0\\.07170911256796775\ \(0\)\
\-\ on\\:\\ 0\\.07126650814991538\ \(0\)\
\-\ oriented\\:\\ 0\\.07091338611939875\ \(0\)\
\-\ face\\:\\ 0\\.07091338611939875\ \(0\)\
\-\ suggesting\\:\\ 0\\.07091338611939875\ \(0\)\
\-\ six\\:\\ 0\\.07065803131582306\ \(0\)\
\-\ larger\\:\\ 0\\.07040731958504753\ \(0\)\
\-\ ankle\\:\\ 0\\.06944771401671977\ \(0\)\
\-\ shift\\:\\ 0\\.06910440752041443\ \(0\)\
\-\ received\\:\\ 0\\.0684424196639522\ \(0\)\
\-\ light\\:\\ 0\\.0681229745204104\ \(0\)\
\-\ aggressive\\:\\ 0\\.06801811648415003\ \(0\)\
\-\ sensation\\:\\ 0\\.06740518156208836\ \(0\)\
\-\ phase\\:\\ 0\\.06730562325724401\ \(0\)\
\-\ started\\:\\ 0\\.06625545212458864\ \(0\)\
\-\ seizure\\:\\ 0\\.06545199582512973\ \(0\)\
\-\ neurological\\:\\ 0\\.0646109568037831\ \(0\)\
\-\ not\\:\\ 0\\.06210314170001168\ \(0\)\
\-\ with\\:\\ 0\\.061607417894115245\ \(0\)\
\-\ of\\:\\ 0\\.061570629457685745\ \(0\)\
\-\ deep\\:\\ 0\\.06122747380649193\ \(0\)\
\-\ progressive\\:\\ 0\\.06024214292227312\ \(0\)\
\-\ matter\\:\\ 0\\.059890070213129705\ \(0\)\
\-\ extremities\\:\\ 0\\.05977468238230033\ \(0\)\
\-\ midline\\:\\ 0\\.05915675243561672\ \(0\)\
\-\ like\\:\\ 0\\.05846047268055996\ \(0\)\
\-\ course\\:\\ 0\\.05809962458429542\ \(0\)\
\-\ confirmed\\:\\ 0\\.05799823614721077\ \(0\)\
\-\ greater\\:\\ 0\\.05794782013010142\ \(0\)\
\-\ throughout\\:\\ 0\\.057847537758498276\ \(0\)\
\-\ 40\\:\\ 0\\.057847537758498276\ \(0\)\
\-\ weakness\\:\\ 0\\.05740507951969675\ \(0\)\
\-\ including\\:\\ 0\\.05629022893380808\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.055851059159231\ \(0\)\
\-\ extension\\:\\ 0\\.055679234315037865\ \(0\)\
\-\ typically\\:\\ 0\\.05521746690698658\ \(0\)\
\-\ biopsy\\:\\ 0\\.05513514567550028\ \(0\)\
\-\ was\\:\\ 0\\.05482488318032757\ \(0\)\
\-\ side\\:\\ 0\\.054337885181725484\ \(0\)\
\-\ areas\\:\\ 0\\.053402060373369704\ \(0\)\
\-\ week\\:\\ 0\\.05290447361359553\ \(0\)\
\-\ radiation\\:\\ 0\\.05212408923471642\ \(0\)\
\-\ white\\:\\ 0\\.051895089055037924\ \(0\)\
\-\ revealed\\:\\ 0\\.05157440564062124\ \(0\)\
\-\ area\\:\\ 0\\.05095458150266905\ \(0\)\
\-\ will\\:\\ 0\\.05062519250975874\ \(0\)\
\-\ clinical\\:\\ 0\\.04984856043596235\ \(0\)\
\-\ brain\\:\\ 0\\.04903402649204762\ \(0\)\
\-\ decreased\\:\\ 0\\.048721224450916846\ \(0\)\
\-\ primary\\:\\ 0\\.04836503727612413\ \(0\)\
\-\ abnormal\\:\\ 0\\.047255552348237875\ \(0\)\
\-\ weeks\\:\\ 0\\.047140164517408496\ \(0\)\
\-\ region\\:\\ 0\\.04704854447721521\ \(0\)\
\-\ edema\\:\\ 0\\.04691224585193252\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04684459846203359\ \(0\)\
\-\ presented\\:\\ 0\\.045867802390483416\ \(0\)\
\-\ than\\:\\ 0\\.044587926331564894\ \(0\)\
\-\ mild\\:\\ 0\\.044587926331564894\ \(0\)\
\-\ patients\\:\\ 0\\.04424837733332568\ \(0\)\
\-\ tumor\\:\\ 0\\.041141721909867895\ \(0\)\
\-\ most\\:\\ 0\\.040935034191495544\ \(0\)\
\-\ small\\:\\ 0\\.0405734831868064\ \(0\)\
\-\ present\\:\\ 0\\.04036101726794268\ \(0\)\
\-\ exam\\:\\ 0\\.039595537426923524\ \(0\)\
\-\ may\\:\\ 0\\.03958224704968446\ \(0\)\
\-\ presents\\:\\ 0\\.03783766074079084\ \(0\)\
\-\ lesion\\:\\ 0\\.03770950061369373\ \(0\)\
\-\ within\\:\\ 0\\.036226590056442104\ \(0\)\
\-\ are\\:\\ 0\\.029846425766330887\ \(0\)\
\-\ at\\:\\ 0\\.02970941774455678\ \(0\)\
\-\ pain\\:\\ 0\\.028146059557414508\ \(0\)\
\-\ left\\:\\ 0\\.026831322953543048\ \(0\)\
\-\ to\\:\\ 0\\.01966387910970758\ \(0\)\
